Insiders · IPSC

IPSC insider transactions

Century Therapeutics Inc. (IPSC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for IPSC

• 19d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.84% to 3,679,786 units (SEC Form 4) to satisfy withholding tax

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 32d
  SVP Finance & Operations Carr Douglas sold $618 worth of shares (264 units at $2.34), decreasing direct ownership by 0.05% to 506,997 units (SEC Form 4) (for withholding tax)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 58d
  SEC Form 4 filed by Murphy Martin Patrick

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 58d
  SEC Form 3 filed by new insider Murphy Martin Patrick

  3 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 65d
  SEC Form 4 filed by Cowan Chad

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 83d
  SVP Finance & Operations Carr Douglas sold $17,953 worth of shares (7,043 units at $2.55), decreasing direct ownership by 1% to 507,261 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 83d
  Officer Russotti Gregory sold $25,684 worth of shares (10,076 units at $2.55), decreasing direct ownership by 2% to 515,427 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 86d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 55,397 shares, decreasing direct ownership by 1% to 3,710,958 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 86d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,431 shares, decreasing direct ownership by 0.12% to 1,177,045 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 88d
  SEC Form 4 filed by Century Therapeutics Inc.

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 88d
  SVP Finance & Operations Carr Douglas sold $626 worth of shares (247 units at $2.54), decreasing direct ownership by 0.05% to 514,304 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 89d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,766,355 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 109d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 31,172 shares, decreasing direct ownership by 0.82% to 3,766,818 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 122d
  SVP Finance & Operations Carr Douglas sold $589 worth of shares (323 units at $1.82), decreasing direct ownership by 0.06% to 514,551 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 123d
  President and CEO Pfeiffenberger Brent was granted 475,000 shares, increasing direct ownership by 14% to 3,797,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 123d
  Officer Russotti Gregory was granted 135,000 shares, increasing direct ownership by 35% to 525,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 123d
  Chief Scientific Officer Cowan Chad was granted 135,000 shares, increasing direct ownership by 13% to 1,178,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 123d
  SVP Finance & Operations Carr Douglas was granted 110,000 shares, increasing direct ownership by 27% to 514,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 152d
  Chief Scientific Officer Cowan Chad covered exercise/tax liability with 1,611 shares, decreasing direct ownership by 0.15% to 1,043,476 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 160d
  Chief Scientific Officer Cowan Chad bought $49,252 worth of shares (58,060 units at $0.85), increasing direct ownership by 6% to 1,045,087 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 173d
  President and CEO Pfeiffenberger Brent bought $30,352 worth of shares (52,000 units at $0.58), increasing direct ownership by 2% to 3,322,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 177d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 463 shares, decreasing direct ownership by 0.01% to 3,270,990 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 178d
  SEC Form 4 filed by Director Lee Han Myung

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 178d
  SEC Form 3 filed by new insider Lee Han Myung

  3 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 179d
  SVP Finance & Operations Carr Douglas sold $137 worth of shares (257 units at $0.53), decreasing direct ownership by 0.06% to 404,874 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 179d
  Officer Russotti Gregory sold $280 worth of shares (526 units at $0.53), decreasing direct ownership by 0.13% to 390,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 195d
  Chief Scientific Officer Cowan Chad sold $2,736 worth of shares (5,462 units at $0.50), decreasing direct ownership by 0.55% to 987,027 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 199d
  President and CEO Pfeiffenberger Brent bought $17,328 worth of shares (35,000 units at $0.50), increasing direct ownership by 1% to 3,271,453 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 200d
  President and CEO Pfeiffenberger Brent sold $14,735 worth of shares (32,456 units at $0.45), decreasing direct ownership by 0.99% to 3,236,453 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 214d
  SVP Finance & Operations Carr Douglas sold $171 worth of shares (292 units at $0.59), decreasing direct ownership by 0.07% to 405,131 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 258d
  Chief Scientific Officer Cowan Chad was granted 762,543 shares, increasing direct ownership by 332% to 992,489 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 270d
  SVP Finance & Operations Carr Douglas sold $132 worth of shares (263 units at $0.50), decreasing direct ownership by 0.06% to 405,423 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 270d
  President and CEO Pfeiffenberger Brent sold $244 worth of shares (488 units at $0.50), decreasing direct ownership by 0.01% to 3,268,909 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 270d
  Officer Russotti Gregory sold $270 worth of shares (539 units at $0.50), decreasing direct ownership by 0.14% to 391,508 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 293d
  President and CEO Pfeiffenberger Brent was granted 1,587,614 shares, increasing direct ownership by 94% to 3,269,397 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 305d
  SVP Finance & Operations Carr Douglas sold $158 worth of shares (296 units at $0.53), decreasing direct ownership by 0.07% to 405,686 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Blackwell Kimberly

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Jimenez Joseph

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Riva Alessandro

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Carlo Rizzuto

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Quimi Daphne

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Butitta Cynthia M

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 356d
  SEC Form 4 filed by Director Walbert Timothy P

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 361d
  SVP Finance & Operations Carr Douglas sold $3,050 worth of shares (4,904 units at $0.62), decreasing direct ownership by 1% to 405,982 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 361d
  Chief Operations Officer Farid Adrienne sold $343 worth of shares (552 units at $0.62), decreasing direct ownership by 0.22% to 250,141 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 361d
  President and CEO Pfeiffenberger Brent sold $295 worth of shares (475 units at $0.62), decreasing direct ownership by 0.03% to 1,681,783 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 361d
  Officer Russotti Gregory sold $327 worth of shares (526 units at $0.62), decreasing direct ownership by 0.13% to 392,047 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 383d
  President and CEO Pfeiffenberger Brent sold $16,135 worth of shares (29,552 units at $0.55), decreasing direct ownership by 2% to 1,682,258 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 396d
  Chief Operations Officer Farid Adrienne sold $563 worth of shares (1,024 units at $0.55), decreasing direct ownership by 0.41% to 250,693 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 396d
  SVP Finance & Operations Carr Douglas sold $162 worth of shares (295 units at $0.55), decreasing direct ownership by 0.07% to 410,886 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  Chief Finanical Officer Conn Morgan was granted 19,500 shares, increasing direct ownership by 32% to 79,648 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  Chief Scientific Officer Cowan Chad was granted 19,500 shares, increasing direct ownership by 9% to 230,306 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  President and CEO Pfeiffenberger Brent was granted 521,500 shares and sold $1,375 worth of shares (2,235 units at $0.61), increasing direct ownership by 44% to 1,711,810 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  Officer Russotti Gregory sold $1,451 worth of shares (2,360 units at $0.61) and was granted 120,000 shares, increasing direct ownership by 43% to 392,573 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  Chief Operations Officer Farid Adrienne sold $1,451 worth of shares (2,359 units at $0.61) and was granted 120,000 shares, increasing direct ownership by 88% to 251,717 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 452d
  SVP Finance & Operations Carr Douglas sold $763 worth of shares (1,240 units at $0.61) and was granted 95,625 shares, increasing direct ownership by 30% to 411,181 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 472d
  President and CEO Pfeiffenberger Brent sold $27,179 worth of shares (34,712 units at $0.78), decreasing direct ownership by 3% to 1,192,545 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 487d
  Chief Operations Officer Farid Adrienne sold $822 worth of shares (1,054 units at $0.78), decreasing direct ownership by 0.78% to 134,076 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 487d
  SVP Finance & Operations Carr Douglas sold $274 worth of shares (351 units at $0.78), decreasing direct ownership by 0.11% to 316,796 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)
• 548d
  President and CEO Pfeiffenberger Brent covered exercise/tax liability with 243,447 shares, decreasing direct ownership by 17% to 1,227,257 units (SEC Form 4)

  4 - Century Therapeutics, Inc. (0001850119) (Issuer)